Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -7.57EBITDA per Share
VS
Market
Sector
Industry
History
$ 2.52Close
$ 2 - $ 29.07 52-Week Range
Ticker Information
Ticker
BBLGCompany Name
BONE BIOLOGICS CORPSector
HealthcareIndustry
Medical DevicesExchange
NASDAQBONE BIOLOGICS CORP - EBITDA per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BBLG - EBITDAPS Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -4.22M | $ -7.57 | 1 | 557.79K |
| 3/31/2025 | $ -4.26M | $ -8.04 | 1 | 530.53K |
| 12/31/2024 | $ -4.11M | $ -16.26 | 1 | 252.87K |
| 9/30/2024 | $ -4.14M | $ -14.17 | 1 | 292.24K |
| 6/30/2024 | $ -5.12M | $ -26.29 | 1 | 194.74K |
| 3/31/2024 | $ -6.1M | $ -55.42 | 1 | 110.16K |
| 12/31/2023 | $ -8.95M | $ -204.05 | 1 | 43.86K |
| 9/30/2023 | $ -6.51M | $ -99.65 | 1 | 65.3K |
| 6/30/2023 | $ -5.81M | $ -266.2 | 1 | 21.81K |
| 3/31/2023 | $ -4.51M | $ -402.7 | 1 | 11.19K |
Key Performance Insights, Last 5 Years
- BONE BIOLOGICS CORP's latest trailing twelve months (TTM) EBITDAPS stands at $ -408.02.
- Over the past 5 years, BONE BIOLOGICS CORP's average EBITDAPS has been $ -200.83.
- The median EBITDAPS for BONE BIOLOGICS CORP during this period was $ -204.05
- BONE BIOLOGICS CORP reached its highest EBITDAPS over the past 5 years at $ -7.57.
- The lowest EBITDAPS recorded by BONE BIOLOGICS CORP in the same timeframe $ -419.89
Similar metrics to Shares WA:
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBITDA per Share
[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for BONE BIOLOGICS CORP is calculated as follows: EBITDA [ $ -825.01K ] / (Shares WA [ 2.02K ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -408.02 ] BBLG - EBITDA per Share, Last 5 years
$ -419.89
Minimum
Sep 30, 2021
$ -7.57
Maximum
Jun 30, 2025
$ -200.83
Average
$ -204.05
Median
EBITDAPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
| filtered constituents | 3.78K |
|---|---|
| min | $ -11.29 |
| max | $ 14.03 |
| average | $ 2.03 |
| median | $ 1 |
| std | $ 4.28 |